A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...
New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...
A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but ...
Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...
A blood test that searches for traces of tumor DNA may detect lung cancer returning before a new tumor becomes visible on a ...
Welltica+ on MSN
A blood test promises to detect over 50 cancers early but a major trial has revealed a problem
A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...
The updates improve upon the option for a first-line screening tool for those who are unable or unwilling to receive the more ...
Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after ...
Singapore blood test CIRRHOClear could help detect liver cirrhosis risk early and prevent liver failure and liver cancer.
Researchers at USC have launched an early-stage clinical trial to investigate whether a blood test could help detect breast ...
Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results